DIFFERENTIAL INTERACTIONS OF STEROIDOGENIC CYTOCHROME P450 17A1 WITH ITS SUBSTRATES

被引：0
作者：
Petrunak, Elyse M. [1 ]
DeVore, Natasha [2 ]
Scott, Emily E. [1 ]
机构：
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P65
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [21] Inhibitors of cytochrome P450 17A1 that spare 21-hydroxylase activity
    Vogt, Caleb
    Fehl, Charlie
    Yadav, Rahul
    Li, Kelin
    Scott, Emily
    Aube, Jeffrey
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [22] Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma
    Skibola, CF
    Lightfoot, T
    Agana, L
    Smith, A
    Rollinson, S
    Kao, A
    Adamson, P
    Morgan, GJ
    Smith, MT
    Roman, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 618 - 621
  • [23] Structures and function of cytochrome P450 17A1: Drug target for metastatic prostate cancer
    Scott, Emily E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [24] Structural features and dynamic investigations of the membrane-bound cytochrome P450 17A1
    Cui, Ying-Lu
    Xue, Qiao
    Zheng, Qing-Chuan
    Zhang, Ji-Long
    Kong, Chui-Peng
    Fan, Jing-Rong
    Zhang, Hong-Xing
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (10): : 2013 - 2021
  • [25] Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1)
    Lee, Sung-Gyu
    Kim, Vitchan
    Lee, Gyu-Hyeong
    Kim, Changmin
    Jeong, Eunseo
    Guengerich, F. Peter
    Kim, Donghak
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2023, 240
  • [26] Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
    Natasha M. DeVore
    Emily E. Scott
    Nature, 2012, 482 : 116 - 119
  • [27] Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
    DeVore, Natasha M.
    Scott, Emily E.
    NATURE, 2012, 482 (7383) : 116 - U149
  • [28] Structure-based optimisation of non-steroidal cytochrome P450 17A1 inhibitors
    Larsen, Morten
    Hansen, Cecilie H.
    Rasmussen, Tobias B.
    Islin, Julie
    Styrishave, Bjarne
    Olsen, Lars
    Jorgensen, Flemming Steen
    CHEMICAL COMMUNICATIONS, 2017, 53 (21) : 3118 - 3121
  • [29] Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
    Norris, John D.
    Ellison, Stephanie J.
    Baker, Jennifer G.
    Stagg, David B.
    Wardell, Suzanne E.
    Park, Sunghee
    Alley, Holly M.
    Baldi, Robert M.
    Yllanes, Alexander
    Andreano, Kaitlyn J.
    Stice, James P.
    Lawrence, Scott A.
    Eisner, Joel R.
    Price, Douglas K.
    Moore, William R.
    Figg, William D.
    McDonnell, Donald P.
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (06) : 2326 - 2338
  • [30] CONTROL OF CYTOCHROME P450 17A1 ANDROGEN SYNTHESIS: ROLES OF SELECT GENOMIC AND ARTIFICIAL MUTANTS
    Scott, Emily
    DRUG METABOLISM REVIEWS, 2012, 44 : 19 - 19
12345